Meet Destina Genomics
at Booth #87
See how our Destina Chemistry catches liver toxicity signals earlier and more specifically than standard liver enzymes such as ALT/AST.
Limited meeting slots · September 13–16, Vienna
What You'll Find at Booth #87
Traditional ALT/AST biomarkers lack specificity and rise late. Come see the PCR-free Destina Chemistry built to catch liver toxicity earlier and more specifically.
The Challenge of Liver Toxicity in Drug Development
ALT & AST Are
Misleading You Twice.
miRNA-122
The most liver-specific DILI biomarker. One PCR-free workflow. Early hepatocellular stress detection with single-nucleotide isomiR resolution.
Exploring a Technology License?
Destina Chemistry transforms your existing immunoassay platform into a molecular workstation, adding miRNA and isomiR detection to your menu without new hardware investment. If you're a platform provider or IVD company, our team at Booth #87 can walk you through the licensing pathway.
Meet Us in Vienna
Destina Genomics will be represented by:
Three decades leading diagnostics commercialization across US, EU and APAC markets. At Eurotox to discuss LiverAce™ deployment, Destina Chemistry licensing, and opportunities for strategic partners.
Ten years developing Destina Chemistry across immunoassay platforms and LiverAce™ kits. Scientific background now applied to product management and commercial partnerships across Europe.
Book a Meeting at Booth #87
Reserve time with Todd or Antonio during Eurotox 2026: kits, licensing, or a custom assay for your biomarkers.
By submitting this form, you agree to our privacy policy.
Human verification is required to prevent automated spam.
See You in Vienna
Whether you're evaluating a kit, exploring a licensing model, or developing a custom miRNA assay: our team is there to talk.
Book a Meeting at Booth #87Limited slots · September 13–16, 2026 · Austria Center Vienna